Study of fungal resistance in skin infections
Part of Infections, Skin clinical trials.
This trial looks for fungal infections that are hard to treat and studies how common resistance is. It may help your doctor choose the right medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a fungal skin infection diagnosed by a doctor.
- You have not used any antifungal cream or pills for this infection yet.
- You are any age and either male or female.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Candida infections form biofilms (protective coatings) and resist antifungal treatments. It may help find better ways to treat serious Candida infections in people with weakened immune systems or after medical procedures.
This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
This study looks at how well medicines work against different types of fungi and whether some fungi are becoming resistant to treatment. If you have a fungal infection, this study could help doctors learn more about how to treat it better.
This early-phase study tests a spray solution (APR-TD011®) for people with early-stage mycosis fungoides and looks at how the bacteria on the skin change before and after treatment. It may help researchers understand whether the spray improves the skin environment that can affect this lymphoma.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
Hear when a new Dermatophyte Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.